뉴스
- Samsung Bio·VUNO Fall on Rights Offerings…SHINPOONG·CHO-A↑[K-Bio Pulse] On Aug. 28, major pharmaceutical and biotech companies saw mixed stock performances as investors responded
- Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse] On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies demonstrating clear earnings growth and solid momentum stood out.
- Onconic Surges on Jaqbo’s India Approval[K-Bio Pulse] South Korea’s pharmaceutical and life sciences sectors advanced in tandem on Aug. 6, led by Onconic Therapeutics, Qurient and Voronoi.The pharmaceutical index gained 2.24%, with 97 of 161 stock...
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
- Will Investment Sentiment Return to Bio Amid Tech Adjustment? KM Pharmaceutical and Lemon Healthc... As the domestic stock market recently enters a breathing spell focused on semiconductors and key Information
- Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse] On July 23, the domestic stock market surged as artificial intelligence (AI) investment expectations combined with strong momentum in healthcare and biotechnology stocks.
- Chasing High Returns Despite Risks? Three "Problematic" Bio Stocks Land Among Top 15 Ga... As the domestic stock market enters a correction phase, loose liquidity is flowing back into the pharmaceutical and bio sectors.
- Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse] While the domestic stock market has recently remained mixed and struggled to find a clear direction, the pharmaceutical and biotech sectors have carved out an upward trajectory.
- Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ... South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the sessio...
- BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal[K-Bio Pulse... On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains.
1 페이지
다음 →